Breaking News Stories

TennCare’s coverage of obesity medication benefits people in Tennessee

Tenncare, Tennessee’s Medicaid program, has recently decided to cover the costs of semaglutide drugs intended for weight loss.

In April 2024, I emphasized to Tenncare and the Tennessee Legislature the importance of taking obesity seriously. The recent expansions in coverage for obesity medications represent more than just updates in policy. For many Tennesseans, it’s like a lifeline. It’s actually pretty unusual for our state to take the lead on addressing such a critical health concern.

I’ve dealt with obesity my entire life. I understand the health risks associated with it, the stigma of being weighed, and those unsolicited comments from others—along with the frustrating reactions from healthcare providers who often simplify this complex issue to just “eat less and walk more.” It’s been a long fight for me to get the care I really need.

Having served as the past chair of the Obesity Action Coalition, I’ve been involved in efforts alongside advocates, clinicians, and policymakers to better recognize obesity as a chronic condition and to improve insurance coverage. This recent decision feels like a win for those of us living with obesity in Tennessee.

Obesity affects more than 40% of adults in the U.S., yet access to treatment can vary significantly depending on where someone lives and their insurance. Tennessee’s decision to broaden coverage for obesity medications comes at a time when other states are actually cutting back on such services. There’s solid evidence showing that comprehensive obesity treatment can lead to better health outcomes and lower long-term healthcare costs. Many people struggling with this issue can now access medications along with nutritional and behavioral support, even surgery if needed.

By allowing Medicaid enrollees access to FDA-approved obesity medications, Tenncare is clearly stating that individuals facing obesity deserve evidence-based care instead of judgment or denial. Obesity is a disease, and it should be treated with the same seriousness as diabetes or heart disease.

This isn’t just a win for Tennessee; it highlights how state-level actions can effect change even when progress at the federal level is slow. Other states should really look at Tennessee’s decisions and consider, “Why can’t we do the same?” Improving access to obesity care is crucial for better public health and a more equitable healthcare system.

Moreover, these coverage decisions can help reduce the stigma attached to obesity, reinforcing that it’s a complex interaction of biology, environment, and genetics, rather than merely a personal failing.

These changes didn’t happen overnight. They’ve come as a result of persistent advocacy from advocates within the obesity community, healthcare providers, and organizations like the OAC.

Tenncare’s actions mark a significant step forward, promoting the idea that everyone deserves access to the necessary care, and this should only be the beginning of broader change.